MABSC

MABSC is funded by a grant from the NHMRC to CI Claire Wainwright and team.

It is a platform trial to evaluate the efficacy of antibiotic therapy combinations in clearing Mycobacterium abscessus pulmonary disease. It will provide a pipeline for new therapies to be evaluated for treating MABS-PD in all age groups.

You can find out more from MABSC’s registration on ANZCTR.